Bourne Lent Asset Management’s Boston Scientific BSX Stock Holding History

Bourne Lent Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$789K	Sell	12,577 -1,821	-13%	-$146K	0.29%	37
2025 Q4	$1.37M	Hold	14,398	–	–	0.46%	30
2025 Q3	$1.41M	Hold	14,398	–	–	0.5%	29
2025 Q2	$1.55M	Sell	14,398 -1,500	-9%	-$152K	0.6%	28
2025 Q1	$1.6M	Sell	15,898 -50	-0.3%	-$5.04K	0.69%	27
2024 Q4	$1.42M	Sell	15,948 -1,821	-10%	-$160K	0.54%	29
2024 Q3	$1.49M	Hold	17,769	–	–	0.57%	29
2024 Q2	$1.37M	Hold	17,769	–	–	0.52%	28
2024 Q1	$1.22M	Hold	17,769	–	–	0.49%	29
2023 Q4	$1.03M	Hold	17,769	–	–	0.42%	28
2023 Q3	$938K	Hold	17,769	–	–	0.41%	29
2023 Q2	$961K	Hold	17,769	–	–	0.34%	30
2023 Q1	$889K	Hold	17,769	–	–	0.34%	33
2022 Q4	$822K	Buy	17,769 +50	+0.3%	+$2.17K	0.35%	32
2022 Q3	$686K	Hold	17,719	–	–	0.3%	33
2022 Q2	$660K	Hold	17,719	–	–	0.26%	33
2022 Q1	$785K	Hold	17,719	–	–	0.25%	36
2021 Q4	$753K	Hold	17,719	–	–	0.2%	37
2021 Q3	$769K	Hold	17,719	–	–	0.22%	36
2021 Q2	$758K	Hold	17,719	–	–	0.21%	36
2021 Q1	$685K	Hold	17,719	–	–	0.22%	37
2020 Q4	$637K	Sell	17,719 -70	-0.4%	-$2.52K	0.21%	36
2020 Q3	$680K	Hold	17,789	–	–	0.26%	31
2020 Q2	$625K	Hold	17,789	–	–	0.27%	33
2020 Q1	$580K	Hold	17,789	–	–	0.31%	32
2019 Q4	$804K	Hold	17,789	–	–	0.38%	28
2019 Q3	$724K	Hold	17,789	–	–	0.35%	29
2019 Q2	$765K	Hold	17,789	–	–	0.37%	28
2019 Q1	$683K	Hold	17,789	–	–	0.34%	30
2018 Q4	$629K	Hold	17,789	–	–	0.37%	28
2018 Q3	$685K	Hold	17,789	–	–	0.33%	30
2018 Q2	$582K	Hold	17,789	–	–	0.31%	33
2018 Q1	$486K	Hold	17,789	–	–	0.26%	39
2017 Q4	$441K	Buy	17,789 +2,185	+14%	+$60.3K	0.24%	44
2017 Q3	$455K	Hold	15,604	–	–	0.23%	40
2017 Q2	$433K	Hold	15,604	–	–	0.24%	41
2017 Q1	$388K	Hold	15,604	–	–	0.21%	44
2016 Q4	$338K	Buy	15,604 +4,500	+41%	+$98.2K	0.2%	45
2016 Q3	$264K	Hold	11,104	–	–	0.19%	48
2016 Q2	$260K	Hold	11,104	–	–	0.2%	47
2016 Q1	$209K	Hold	11,104	–	–	0.17%	49
2015 Q4	$205K	Sell	11,104 -400	-3%	-$7.17K	0.16%	49
2015 Q3	$189K	Hold	11,504	–	–	0.16%	49
2015 Q2	$204K	Sell	11,504 -1,932	-14%	-$34.5K	0.16%	50
2015 Q1	$238K	Buy	+13,436	New	+$212K	0.18%	50

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bourne Lent Asset Management's BSX Position: Q1 2026 in Review

Bourne Lent Asset Management reduced its Boston Scientific (BSX) stake by 13% in Q1 2026, selling an estimated $146K and leaving 12,577 shares worth $789K. The position accounts for 0.29% of the portfolio, ranked #37.

Bourne Lent Asset Management first reported a position in BSX in Q1 2015 and has held it in 45 quarters since. The position peaked at $1.6M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Bourne Lent Asset Management held 12,577 shares of Boston Scientific worth $789K as of Q1 2026.
Bourne Lent Asset Management sold 1,821 Boston Scientific shares in Q1 2026, an estimated $146K.
Boston Scientific made up 0.29% of Bourne Lent Asset Management's portfolio in Q1 2026, its #37 holding.
Bourne Lent Asset Management first reported a position in Boston Scientific in Q1 2015 and has held it in 45 quarters since.
Bourne Lent Asset Management's Boston Scientific position peaked at $1.6M in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bourne Lent Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.